Giant Cell Arteritis and Angiogenesis: A Review

REFERENCES

• Bloch D A, Michel B A, Hunder G G, McShane D J, Arend W P, Calabrese L H, et al. The American College of Rheumatology 1990 Criteria for the Classification of Vasculitis. Patients and methods. Arthritis Rheum 1990; 33(8)1068–1073
   PubMedGoogle Scholar
• Carroll S C, Gaskin B J, Danesh-Meyer H V. Giant cell arteritis. Clin Experiment Ophthalmol 2006; 34(2)159–173
   PubMedGoogle Scholar
• Caselli R J, Hunder G G, Whisnant J P. Neurologic disease in biopsy-proven giant cell (temporal) arteritis. Neurology 1998; 38(3)352–359
   Google Scholar
• Cid M C, Hernandez-Rodriguez J, Esteban M, Mireia Cebrian G S, Gho Y, Font C, Urbano-Marquez A, Grau J M, Kleinman H K. Tissue and serum angiogenic activity is associated with low prevalence of ischemic complications in patients with giant-cell arterits. Circulation 2002; 106: 1664–1671
   PubMed Web of Science ®Google Scholar
• Danesh-Meyer H V, Savino P J. Giant cell arteritis. Curr Opin Ophthalmol 2007; 8(6)443–449
   Google Scholar
• Danesh-Meyer H V, Savino P J, Eagle R C, Kubis K C, Sergott R C. Low diagnostic yield with second biopsies in suspected giant cell arteritis. J Neuroophthalmol 2000; 20(3)213–215
   PubMedGoogle Scholar
• Foroozan R, Danesh-Meyer H, Savino P J, Gamble G, Mekari-Sabbagh O N, Sergott R C. Thrombocytosis in patients with biopsy-proven giant cell arteritis. Ophthalmology 2002; 109(7)1267–1271
   PubMed Web of Science ®Google Scholar
• Gonzalez-Gay M A, Garcia-Porrua C, Pineiro A, Pego-Reigosa R, Llorca J, Hunder G G. Aortic aneurysm and dissection in patients with biopsy-proven giant cell arteritis from northwestern spain: A population-based study. Medicine 2004; 83(6)335–341
   PubMed Web of Science ®Google Scholar
• Hayreh S S, Jonas J B. Optic disc morphology after arteritic anterior ischemic optic neuropathy. Ophthalmology 2001; 108(9)1586–1594
   PubMed Web of Science ®Google Scholar
• Hayreh S S, Podhajsky P A, Raman R, Zimmerman B. Giant cell arteritis: Validity and reliability of various diagnostic criteria. Am J Ophthalmol 1997; 123(3)285–296
   PubMed Web of Science ®Google Scholar
• Hayreh S S, Podhajsky P A, Zimmerman B. Ocular manifestations of giant cell arteritis. Am J Ophthalmol 1998; 125(4)509–520
   PubMed Web of Science ®Google Scholar
• Hernandez-Rodriguez J, Segarra M, Vilardell C, Sanchez M, Garcia-Martinez A, Estaban M, Grau J, Urbano-Marquez A, Colomer D, Kleinman H, Cid M C. Elevated production of interleukin-6 is associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis: angiogenic activity of interleukin-6 as a potential protective mechanism. Circulation 2003; 107: 2428–2434
   PubMed Web of Science ®Google Scholar
• Kaiser M, Weyand C M, Bjornsson J, Goronzy J J. Platelet-derived growth factor, intimal hyperplasia, and ischemic complications in giant cell arteritis. Arthritis Rheum 1998; 41(4)623–633
   PubMedGoogle Scholar
• Kaiser M, Younge B, Bjornsson J, Goronzy J J, Weyand C M. Formation of new vasa vasorum in vasculitis. Production of angiogenic cytokines by multinucleated giant cells. Am J Pathol 1999; 155(3)765–774
   PubMed Web of Science ®Google Scholar
• Krupa W M, Dewan M, Jeon M S, Kurtin P J, Younge B R, Goronzy J J, et al. Trapping of misdirected dendritic cells in the granulomatous lesions of giant cell arteritis. Am J Pathol 2002; 161(5)1815–1823
   PubMed Web of Science ®Google Scholar
• Makkuni D, Bharadwaj A, Wolfe K, Payne S, Hutchings A, Dasgupta B. Is intimal hyperplasia a marker of neuro-ophthalmic complications of giant cell arteritis?. Rheumatology (Oxford) 2008; 47(4)488–490
   PubMed Web of Science ®Google Scholar
• Nordborg E, Nordborg C. Giant cell arteritis: Epidemiological clues to its pathogenesis and an update on its treatment. Rheumatology (Oxford) 2003; 42(3)413–421
   PubMedGoogle Scholar
• Nuenninghoff D M, Matteson E L. The role of disease-modifying antirheumatic drugs in the treatment of giant cell arteritis. Clin Exp Rheumatol 2003; 21(6 Suppl 32)S29–34, (2003)
   PubMedGoogle Scholar
• Pless M, Rizzo J F, Lamkin J C, Lessell S. Concordance of bilateral temporal artery biopsy in giant cell arteritis. J Neuroophthalmol 2000; 20(3)216–218, (2000)
   PubMedGoogle Scholar
• Proven A, Gabriel S E, Orces C, O'Fallon W M, Hunder G G. Glucocorticoid therapy in giant cell arteritis: Duration and adverse outcomes. Arthritis Rheum 2003; 49(5)703–708
   PubMed Web of Science ®Google Scholar
• Rueda B, Lopez-Nevot M A, Lopez-Diaz M J, Garcia-Porrua C, Martin J, Gonzalez-Gay M A. A functional variant of vascular endothelial growth factor is associated with severe ischemic complications in giant cell arteritis. J Rheumatol 2005; 32(9)1737–1741
   PubMed Web of Science ®Google Scholar
• Salvarani C, Cantini F, Hunder G G. Polymyalgia rheumatica and giant-cell arteritis. Lancet 2008; 372(9634)234–245
   PubMed Web of Science ®Google Scholar
• Tehrani R, Ostrowski R A, Hariman R, Jay W M. Giant cell arteritis. Semin Ophthalmol Mar-Apr, 2008; 23(2)99–110
   PubMedGoogle Scholar
• Weyand C M, Goronzy J J. Arterial wall injury in giant cell arteritis. Arthritis Rheum 1999; 42(5)844–853
   PubMedGoogle Scholar
• Weyand C M, Goronzy J J. Pathogenic mechanisms in giant cell arteritis. Cleve Clin J Med 2002; 69(Suppl 2)SII28–SII32
   PubMed Web of Science ®Google Scholar
• Weyand C M, Goronzy J J. Medium- and large-vessel vasculitis. N Engl J Med 2003; 349(2)160–169
   PubMed Web of Science ®Google Scholar